Lauren S. Kramer

In recognition of her work, Ms. Kramer has been named one of Best Lawyers’ Ones To Watch in America and honored by Lawdragon as one of its 500 X — The Next Generation.

Ms. Kramer’s select representations include:

• Honeywell in its:
  • announced plan to spin off its advanced materials business
  • $4.95 billion acquisition of the global access solutions business of Carrier Global Corporation
  • $1.3 billion acquisition of Sparta Systems from New Mountain Capital
• Berry Global Group, Inc. in its pending $37 billion merger with Amcor
• Air Products and Chemicals, Inc. in the $1.81 billion sale of its liquefied natural gas (LNG) process technology and equipment business to Honeywell
• Keurig Dr Pepper in its strategic partnership and $300 million investment in La Colombe Coffee Roasters
• Activision Blizzard Inc. in its $75 billion acquisition by Microsoft Corporation
• Genesys, a portfolio company of the Permira Funds and Hellman & Friedman, in a $580 million round of funding at a valuation of $21 billion
• Spotify Technology S.A. in its (i) acquisition of Chartable Holding Inc. and (ii) acquisition of Megaphone LLC from Graham Holdings
• OceanSound Partners and its portfolio company Netrix in the acquisition of the managed IT services business unit of Contegix, LLC
• Vital Proteins in its acquisition by Nestlé Health Science
• Mubadala Investment Company in its investment as part of a consortium of $2.25 billion in Waymo
• NXP Semiconductors N.V. in its:
  • $1.8 billion acquisition of Marvell Technology Group Ltd.’s wireless connectivity portfolio
  • proposed (but terminated) $47 billion acquisition by Qualcomm Incorporated
• Permira Funds in several transactions, including:
  • the sale of its portfolio company LSNE to PCI Pharma Services
  • its acquisition of a majority stake in Axiom
  • its acquisition of a majority stake in Reformation
  • its acquisition of a majority stake in Cielo, Inc. from Accel-KKR
  • the $2.3 billion sale of its portfolio company Atrium Innovations to Nestlé S.A.
• Goldman Sachs & Co. as financial advisor in several transactions, including:
  • Turning Point Therapeutics, Inc. in its $4.1 billion sale to Bristol-Myers Squibb Company
  • Covetrus, Inc. in its $4 billion sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital